Dermira, Inc. (DERM) Social Stream



Dermira, Inc. (DERM): $3.56

-0.09 (-2.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DERM to Watchlist
Sign Up

Industry: Biotech


Ranked

of NR

in industry

Journey Medical Corp (DERM) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Journey Medical Corp.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-07 1 $14 $14 $14 $4.85 188.66%
2022-01-13 2 $15 $14 $14.5 $4.85 198.97%
2022-03-25 3 $17 $9 $13.333 $4.85 174.91%
NA 1 $NA $NA $NA $4.85 NA%

Over the past 108 days, DERM's average upside potential has been 157.15%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-07 1 14 14 14.0 7.27 92.57%
2022-01-13 3 15 14 14.5 5.18 179.92%
2022-01-13 2 15 14 14.5 5.18 179.92%
2022-01-13 3 17 14 15.5 5.18 199.23%
2022-01-13 2 17 14 15.5 5.18 199.23%

DERM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Journey Medical Corp's number of analysts covering the stock is higher than 31.7% of them.
  • In the context of all US stocks, Journey Medical Corp's upside potential (average analyst target price relative to current price) is higher than 439.16% of them.
  • DERM has a greater average analyst price target than 76.62% of all US stocks.
  • Journey Medical Corp's variance in analysts' estimates is lower than 0.52% of Healthcare stocks.

In the Pharmaceutical Products industry, DARE, CYCC, and CWBR are the three stocks most similar to Journey Medical Corp regarding the price target and analyst recommendation information presented here.

Is DERM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5986 seconds.